Merck & Co Inc (MRK)
121.45
-0.07
(-0.06%)
USD |
NYSE |
Mar 18, 16:00
121.99
+0.54
(+0.44%)
After-Hours: 20:00
Merck Total Liabilities (Quarterly): 69.04B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 69.04B |
September 30, 2023 | 65.43B |
June 30, 2023 | 65.73B |
March 31, 2023 | 60.89B |
December 31, 2022 | 63.10B |
September 30, 2022 | 62.56B |
June 30, 2022 | 63.78B |
March 31, 2022 | 65.72B |
December 31, 2021 | 67.44B |
September 30, 2021 | 57.63B |
June 30, 2021 | 57.30B |
March 31, 2021 | 63.81B |
December 31, 2020 | 66.18B |
September 30, 2020 | 60.53B |
June 30, 2020 | 62.87B |
March 31, 2020 | 58.61B |
December 31, 2019 | 58.40B |
September 30, 2019 | 56.41B |
June 30, 2019 | 56.23B |
March 31, 2019 | 54.68B |
December 31, 2018 | 55.76B |
September 30, 2018 | 52.47B |
June 30, 2018 | 52.27B |
March 31, 2018 | 52.14B |
December 31, 2017 | 53.30B |
Date | Value |
---|---|
September 30, 2017 | 53.18B |
June 30, 2017 | 53.09B |
March 31, 2017 | 56.47B |
December 31, 2016 | 55.07B |
September 30, 2016 | 54.38B |
June 30, 2016 | 53.03B |
March 31, 2016 | 54.85B |
December 31, 2015 | 56.91B |
September 30, 2015 | 55.55B |
June 30, 2015 | 55.94B |
March 31, 2015 | 60.43B |
December 31, 2014 | 49.38B |
September 30, 2014 | 56.45B |
June 30, 2014 | 49.34B |
March 31, 2014 | 55.90B |
December 31, 2013 | 53.32B |
September 30, 2013 | 56.41B |
June 30, 2013 | 56.77B |
March 31, 2013 | 50.59B |
December 31, 2012 | 50.67B |
September 30, 2012 | 48.09B |
June 30, 2012 | 47.85B |
March 31, 2012 | 48.20B |
December 31, 2011 | 48.18B |
September 30, 2011 | 48.94B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
54.68B
Minimum
Mar 2019
69.04B
Maximum
Dec 2023
61.82B
Average
62.71B
Median
Total Liabilities (Quarterly) Benchmarks
Amgen Inc | 90.92B |
Gilead Sciences Inc | 39.38B |
Johnson & Johnson | 98.78B |
Harpoon Therapeutics Inc (DELISTED) | 43.04M |
Moderna Inc | 4.572B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 106.68B |
Shareholders Equity (Quarterly) | 37.58B |
Debt to Equity Ratio | 0.9328 |
Current Ratio | 1.252 |
Net Debt Paydown Yield | -0.34% |